Literature DB >> 2537874

Detection of anti-rotavirus IgG, IgM, and IgA antibodies in healthy subjects, rotavirus infections, and immunodeficiencies by immunoblotting.

H Ushijima1, H Honma, H Ohnoda, J Mukoyama, H Oyanagi, K Araki, T Shinozaki, S Morikawa, T Kitamura.   

Abstract

Immune responses to individual simian rotavirus (SA 11) structural polypeptides were studied with emphasis on specific IgG, IgM, and IgA in paired sera from four children with rotavirus infections. Responses to simian rotavirus (SA 11) were also studied in 103 healthy children, 10 patients with primary immunodeficiency who received intravenous immunoglobulin, and 11 human immunodeficiency virus antibody-positive patients. All samples were immunoblotted for two major polypeptides--VP2 and VP6--of IgG. Immunoblotted IgA and IgM were elevated 2-4 weeks after the onset of the disease (stage II) in patients with rotavirus infection. Immunoblotted IgG remained almost the same at the onset of the disease and stage II. The scores for primary and secondary immunodeficiency patients were lower than for healthy children. The score obtained by totaling all polypeptides found in each individual was compared with the optical density (OD) value obtained by enzyme immunoassay.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2537874     DOI: 10.1002/jmv.1890270104

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  3 in total

1.  Homotypic serum antibody responses to rotavirus proteins following primary infection of young children with serotype 1 rotavirus.

Authors:  S C Richardson; R F Bishop
Journal:  J Clin Microbiol       Date:  1990-09       Impact factor: 5.948

2.  Serological responses to rotavirus NSP2 following administration of RV3-BB human neonatal rotavirus vaccine.

Authors:  Daniel Cowley; Daniel Pavlic; Nada Bogdanovic-Sakran; Karen Boniface; Carl D Kirkwood; Julie E Bines
Journal:  Hum Vaccin Immunother       Date:  2018-05-31       Impact factor: 3.452

3.  Molecular characterisation of rotavirus strains detected during a clinical trial of the human neonatal rotavirus vaccine (RV3-BB) in Indonesia.

Authors:  Daniel Cowley; Hera Nirwati; Celeste M Donato; Nada Bogdanovic-Sakran; Karen Boniface; Carl D Kirkwood; Julie E Bines
Journal:  Vaccine       Date:  2018-08-23       Impact factor: 3.641

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.